|
| |
BioEmail targeted email lists
Pharmaceutical – Drug Discovery and Development List.
Pharmaceutical – Drug Discovery and Development List.
This is a list focused on those involved in pre-clinical drug discovery
and development.
Current number on list : 175,919*
Regional Breakdown Percentage
-
Europe 39.2%
-
USA 28.8%
-
Rest of World 32.0%
Keywords:
• Drug Discovery
• Pharmacology
• Validation
• ADME
• Toxicology
• Pharmacokinetics
• Drug metabolism
• Drug development
• Drug excretion
• Pharmaceutical
• PhaseI
• Phase1
• Phase I
• Phase 1
• Pharmacokinetics
• Pharmacodynamics
Typically this list is refined to tightly match the needs of specific
clients.
Additional terms to consider
• High Throughput Screening
• Combinatorial Chemistry
Top Countries
-
USA 28.8%
-
Japan 7.9%
-
Germany 4.8%
-
UK 4.8%
-
Italy 3.5%
-
France 3.3%
-
Canada 3.0%
-
Spain 2.0
Sector Distribution
-
Academic (.ac., .edu etc.) 54.4%
-
Commercial (.com, .co.uk etc.) 6.9%
-
Government (.gov etc.) 1.2%
-
Other (Mainly country TLDs eg. .de, .jp
etc.) 38.8%
Example Job Titles:
• Professor
• Senior Scientist
• Researcher
• Toxicologist
• Interventional Cardiologist
• Principle Investigator
Sample Grantholders
xxx@itsa.ucsf.edu
Modeling Complex Pharmacokinetics and Pharmacodynamics
xxx@bme.jhu.edu
Motor learning and memory in health and disease
xxx@compactmembrane.com
Novel Pharmaceutical Solvent - Water Separation System
xxx@mapp-biopharmaceutical.com MONOCLONAL
ANTIBODIES FOR ALZHEIMER'S IMMUNOTHERAPY
xxx@yale.edu
Pharmaceutical Regulation and New Drug Safety
xxx@musc.edu
Pharmacokinetics and Drug Interactions with Milk Thistle
xxx@ohsu.edu
Levodopa Pharmacokinetics and Pharmacodynamics
xxx@molecularinsight.com
High sensitivity and low toxicity radiopharmaceuticals
xxx@uiowa.edu
16th Internat'l Symposium: Radiopharmaceutical Chemistry
xxx@peds.ufl.edu
PHARMACOKINETICS OF INTRAVENOUS RECOMBINANT G-CSF IN NEWBORN INFANTS
xxx@txccc.org
PHARMACOKINETICS OF HYDROXYUREA IN CHILDREN WITH SLD
xxx@cshs.org
PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH
xxx@northwestern.edu
Pharmacokinetics of clinical and commercial lots of testoderm TTS product
xxx@northwestern.edu
PHARMACOKINETICS OF GENISTEIN, TYROSINE KINASE INHIBITOR
Sample Published Authors
xxx@u.washington.edu
Factors influencing regional differences in intestinal absorption of
UK-343,664 in rat: possible role in dose-dependent pharmacokinetics.
xxx@vcp.monash.edu.au
Alteration of the intravenous pharmacokinetics of a synthetic ozonide
antimalarial in the presence of a modified cyclodextrin.
xxx@tuhs.temple.edu
The use of levo-carnitine in children with renal disease: a review and a
call for future studies.
xxx@e-pharmacokinetics.com
The effect of ciprofloxacin and clarithromycin on sildenafil oral
bioavailability in human volunteers.
xxx@chu-montpellier.fr
Neurotoxicity related to valganciclovir in a child with impaired renal
function: usefulness of therapeutic drug monitoring.
xxx@merck.com
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based
inhibitors of VEGFR-2 (KDR) kinase.
xxx@partners.org
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662
administered as a weekly 24 h continuous intravenous infusion in patients
with advanced solid tumors.
xxx@marionegri.it
Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer
patients.
xxx@inet.uni2.dk
PET neuroimaging of [11C]mirtazapine enantiomers in pigs.
xxx@cellzdirect.com
Metabolism and transporter-mediated drug-drug interactions of the endothelin-A
receptor antagonist CI-1034.
xxx@u.washington.edu
Factors influencing regional differences in intestinal absorption of
UK-343,664 in rat: possible role in dose-dependent pharmacokinetics.
Example companies
• Ancorapharma
• Roche
• Wyeth
• L’Oreal
• Agilent
• Genomatica
• Allergan
• Glaxo
• Abbott
• Lilly
• Amersham
* Our database is constantly being updated and edited. Newly published
authors and grant applicants are added daily and emails which become disused
are constantly purged from our system.
| |
|